BUSINESS  DEVELOPMENT

Antigen Express is interested in partnering its development programs in cancer, H5 avian influenza and HIV. In addition, Antigen Express technologies are widely applicable to different immunotherapy strategies.

For further information, please contact:

Eric von Hofe, Ph.D.
President
Antigen Express, Inc.
evonhofe@antigenexpress.com

Tel: (617) 699-1965